World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02159651
Date of registration: 06/06/2014
Prospective Registration: No
Primary sponsor: Astellas Pharma Inc
Public title: A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
Scientific title: Specified Drug Use-results Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Date of first enrolment: April 1, 2014
Target sample size: 179
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02159651
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Japan
Contacts
Name:     Medical Director
Address: 
Telephone:
Email:
Affiliation:  Astellas Pharma Inc
Key inclusion & exclusion criteria

Inclusion Criteria:

- Hospitalized patient

- Patient diagnosed with Interstitial pneumonia associated with
polymyositis/dermatomyositis



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Intervention(s)
Drug: tacrolimus
Primary Outcome(s)
Overall survival [Time Frame: Up to three years]
Secondary Outcome(s)
Arterial blood gas analysis value (PaO2, AaDO2) [Time Frame: Up to three years]
Chest CT findings [Time Frame: Up to three years]
Patient disposition [Time Frame: Up to three years]
Respiratory function test value (%FVC, %DLco) [Time Frame: Up to three years]
Safety assessed by the incidence of adverse events [Time Frame: Up to three years]
Serum KL-6 value (serum SP-D value) [Time Frame: Up to three years]
Secondary ID(s)
506-MA-PRGI-01
PRGI01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history